John Milici
Surgical · Rutherford, NJNPI 1356989495
Payments from drug & device makers
Across 52 payments — averaging $25.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$181
- Pharmacyclics LLC, An Abbvie Company$146
- Amgen$135
- W. L. Gore & Associates, Inc.$135
- Daiichi Sankyo Inc.$106
- Novartis$99
- plus $500 from 18 others
What the payments were for
- Food & beverage$96574%
- Education$33826%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 3 | $181 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $146 |
| Amgen | 6 | $135 |
| W. L. Gore & Associates, Inc. | 1 | $135 |
| Daiichi Sankyo Inc. | 6 | $106 |
| Novartis | 5 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $77 |
| Bayer | 2 | $50 |
| AstraZeneca | 3 | $50 |
| Novo Nordisk | 2 | $36 |
| Merck | 2 | $34 |
| Rigel Pharmaceuticals, Inc. | 2 | $34 |
| Array Biopharma Inc | 2 | $28 |
| Sobi, Inc | 2 | $27 |
| Foundation Medicine, Inc. | 2 | $26 |
| Sanofi | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,303 in reported general payments places this provider in the 75th percentile of 462 surgical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $1,184 |
| Pantoprazole Sodium | 14 | $139 |
Paid to pharmacies, not to this prescriber.
Other surgical in Rutherford
- Matthew PetridesNeptune$183K
- Andrea ConwayCherry Hill$105K
- Dean BaroneUnion$69K
- Jessica HendersonEatontown$53K
- Richard BengelCamden$44K
- Dylan RyanCamden$26K
- Lauren RoyceClifton$11K
- Rachel WintMount Laurel$10K
- Richard HulseNeptune$10K
- Mimi OliffWest Orange$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.